The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension

Bryson, Andrew; Jennings, Paul; Deak, L.; Paveliu, Fraga; Lawson, Matt

doi:10.1080/14656566.2016.1190334

Public

The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension

Published in Expert Opinion on Pharmacotherapy • May 14, 2016

Authors:

Andrew Bryson

Paul Jennings

L. Deak

Abstract

OBJECTIVE: The study investigated the efficacy and tolerability of teneligliptin co-administered to patients with type 2 diabetes mellitus (T2DM) who were inadequately controlled by stable metformin monotherapy ≥ 1000 mg/day. METHODS: A total of 447 patients from 55 European centers who completed a ...

Subject

Medicine

Metformin

Tolerability

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!